Hello Patient Acquires Converse Health to Add Back Office AI Agents

Sep 16, 2026
Hello Patient acquired Converse Health to expand its automation for outpatient medical practices. The combined platform handles patient communications, referrals, records, follow up tasks and authorization paperwork.

Hello Patient acquired Converse Health on September 15, the company said in a press release. The acquisition adds AI agents for administrative work surrounding patient visits to Hello Patient's existing communication tools.

Converse Health's software reads incoming referrals and faxes, matches documents to patient records and files them in electronic health record systems. Its agents also identify overdue follow up tasks, prepare authorization requests for staff review, retrieve imaging and process medical records requests.

Hello Patient already provides agents for calls, texts and web chats, including appointment scheduling, patient intake, billing and refill requests. Converse Health's capabilities are now available through the Hello Patient platform.

Converse Health was founded in 2023 and raised $1.3 million before the acquisition. Co founder Louis Sallerson will join Hello Patient as product leader for back office and specialty workflows.

We hope you enjoyed this article

Free newsletter

AI Funding Brief

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.